Based on the expression status of estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 (HER2), BC is typically classified into four subtypes: Luminal A, Luminal B, HER2-enriched, and triple-negative breast cancer (3). The gene discussed is ERBB2; the disease is triple-negative breast carcinoma.